Paul Skenes and Tarik Skubal capped remarkable 2025 campaigns by taking home Cy Young Awards, each carving out a season that separated them from peers, while questions over their long-term roles with their teams now loom large. This piece looks at how those seasons unfolded, why clubs face tough choices, what the market might do, and how fans and front offices could react going forward.
Both pitchers arrived at the awards after seasons defined by control, velocity, and the kind of late-inning dominance that shifts narratives overnight. Their performances didn’t just win hardware — they forced organizations to confront whether to double down, trade for depth, or reshape payroll around elite pitching. The core issue is not the quality of work, which is obvious, but the business and roster ripple effects that follow.
For teams, elite starting pitching is the most wanted and most fragile asset in baseball. An ace can tilt playoff odds and legitimize an offense that otherwise struggles, but it also creates pressure to build a competitive window fast. That urgency leads clubs to weigh short-term upgrades against long-term flexibility, and Cy Young winners amplify both the opportunity and the dilemma.
On the flip side, maintaining an entire rotation around one or two top arms is risky. Injuries, regression and matchup issues happen, and leaning too heavily on a single talent can leave a roster exposed in October. Smart front offices balance celebrating a superstar season with sober planning to avoid hinging too much of the team’s future on one player’s next contract year.
Trade chatter usually spikes after awards because value spikes with recognition, and rivals take stock of whether an elite pitcher could be the missing piece. Teams that miss playoffs or face a crowded division might shop aggressively, while contenders look at such arms as a way to vault into serious contention. That marketplace tension can force sellers to decide if they want premium prospects now or a longer-term commitment later.
Fan emotion and media narrative intensify every roster decision, which complicates objectively sensible moves. Keeping a Cy Young winner is a feel-good headline, but payroll realities and roster construction can pull front offices in different directions. Balancing optics with roster health is one of the tougher jobs for modern executives, especially when expectations grow after breakout seasons.
Contract timing is another wedge. If arbitration years remain, teams can retain control at reasonable cost, but the looming eventual payday raises questions about how aggressive to be in assembling around that player. If a club sees a narrow championship window, paying up might make sense; if the timeline is longer, trading while value is high could accelerate a rebuild. Either path carries risk, and Cy Young status magnifies the stakes.
From the pitchers’ view, legitimate leverage follows major awards; agents get louder and the narrative of being “untouchable” builds momentum. That can be useful for negotiation but also creates impatience among fans when a team hesitates to match expectations. The best outcomes usually come from clear communication and aligned timelines between player and team, but baseball’s clock rarely matches every stakeholder’s schedule.
Ultimately these Cy Young wins change more than the trophy case — they alter planning, payroll and public pressure for the clubs involved. The hard work now is translating peak performance into sustainable competitiveness without mortgaging the future. Each team faces a distinct puzzle, and the choices they make over the next months will define whether those stellar seasons become the cornerstone of a title run or the peak moment before a reset.
